LU83912A1 - APPLICATION OF BETA AMINO ENONES AS U.V.-A. RADIATION FILTERING AGENTS - Google Patents
APPLICATION OF BETA AMINO ENONES AS U.V.-A. RADIATION FILTERING AGENTS Download PDFInfo
- Publication number
- LU83912A1 LU83912A1 LU83912A LU83912A LU83912A1 LU 83912 A1 LU83912 A1 LU 83912A1 LU 83912 A LU83912 A LU 83912A LU 83912 A LU83912 A LU 83912A LU 83912 A1 LU83912 A1 LU 83912A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- formula
- composition according
- substituted
- composition
- unsubstituted
- Prior art date
Links
- 230000005855 radiation Effects 0.000 title claims description 26
- -1 AMINO Chemical class 0.000 title claims description 14
- 238000001914 filtration Methods 0.000 title claims description 11
- 239000000203 mixture Substances 0.000 claims description 34
- 150000001875 compounds Chemical class 0.000 claims description 20
- 239000003921 oil Substances 0.000 claims description 15
- 235000019198 oils Nutrition 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 11
- 239000001993 wax Substances 0.000 claims description 9
- 230000009471 action Effects 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- DMEGYFMYUHOHGS-UHFFFAOYSA-N cycloheptane Chemical compound C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 239000002304 perfume Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- VYTPDQSCOXJDJM-UHFFFAOYSA-N 2-methylidenecyclohexan-1-one Chemical compound C=C1CCCCC1=O VYTPDQSCOXJDJM-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- UEVXKGPJXXDGCX-UHFFFAOYSA-N cyclotridecane Chemical compound C1CCCCCCCCCCCC1 UEVXKGPJXXDGCX-UHFFFAOYSA-N 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 4
- 125000000623 heterocyclic group Chemical group 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 4
- 229920003023 plastic Polymers 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- RFKOMAKFYFYFSS-UHFFFAOYSA-N 2-(cyclohexylamino)-6-methylidenecyclohexan-1-one Chemical compound C1(CCCCC1)NC1C(C(CCC1)=C)=O RFKOMAKFYFYFSS-UHFFFAOYSA-N 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 210000002615 epidermis Anatomy 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 150000003626 triacylglycerols Chemical class 0.000 claims description 3
- 239000002966 varnish Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 125000002723 alicyclic group Chemical group 0.000 claims description 2
- 239000010775 animal oil Substances 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 150000002194 fatty esters Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000002480 mineral oil Substances 0.000 claims description 2
- 239000011368 organic material Substances 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical class CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 2
- 239000003223 protective agent Substances 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 239000005416 organic matter Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 239000001957 sucroglyceride Substances 0.000 claims 1
- 235000010964 sucroglyceride Nutrition 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000004166 Lanolin Substances 0.000 description 7
- 235000019388 lanolin Nutrition 0.000 description 7
- 229940039717 lanolin Drugs 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000019271 petrolatum Nutrition 0.000 description 4
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000723346 Cinnamomum camphora Species 0.000 description 3
- 239000004264 Petrolatum Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960000846 camphor Drugs 0.000 description 3
- 229930008380 camphor Natural products 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940110456 cocoa butter Drugs 0.000 description 3
- 235000019868 cocoa butter Nutrition 0.000 description 3
- 229940066842 petrolatum Drugs 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000003871 white petrolatum Substances 0.000 description 3
- ORTWDKQPXZLPCA-WAYWQWQTSA-N (2z)-2-(hydroxymethylidene)cyclohexan-1-one Chemical compound O\C=C1\CCCCC1=O ORTWDKQPXZLPCA-WAYWQWQTSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- RQTRKYKFSDPOQR-UHFFFAOYSA-N 2-[(dodecylamino)methylidene]cyclohexan-1-one Chemical compound C(CCCCCCCCCCC)NC=C1C(CCCC1)=O RQTRKYKFSDPOQR-UHFFFAOYSA-N 0.000 description 2
- SXVPOSFURRDKBO-UHFFFAOYSA-N Cyclododecanone Chemical compound O=C1CCCCCCCCCCC1 SXVPOSFURRDKBO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 235000019498 Walnut oil Nutrition 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000010635 coffee oil Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000008170 walnut oil Substances 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- SIGZQOSGZJNAKB-UHFFFAOYSA-N 2-(hydroxymethyl)cyclohexan-1-one Chemical compound OCC1CCCCC1=O SIGZQOSGZJNAKB-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000273930 Brevoortia tyrannus Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000276438 Gadus morhua Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 241001233242 Lontra Species 0.000 description 1
- 241000283923 Marmota monax Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- ONABWIMMCUZILP-UHFFFAOYSA-N ethyl 4-(dimethylamino)-2-hexylbenzoate Chemical compound CCCCCCC1=CC(N(C)C)=CC=C1C(=O)OCC ONABWIMMCUZILP-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- YAGMLECKUBJRNO-UHFFFAOYSA-N octyl 4-(dimethylamino)benzoate Chemical compound CCCCCCCCOC(=O)C1=CC=C(N(C)C)C=C1 YAGMLECKUBJRNO-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 235000020233 pistachio Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/411—Aromatic amines, i.e. where the amino group is directly linked to the aromatic nucleus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
1283/81 LU 295 2.45461283/81 LU 295 2.4546
" " ‘ —Ji «RAND-DUCHÉ DE LUXEMBOURG"" ‘—Ji« RAND-DUCHÉ OF LUXEMBOURG
tN°......Q o d ! LtN ° ...... Q o d! L
du 2 9.-4 an Vier......1982... ÿèÊÈ Monsieur le Ministre gÖsGjg de l’Économie et des Classes Moyennesfrom 2 9.-4 year Vier ...... 1982 ... ÿèÊÈ Minister gÖsGjg of the Economy and the Middle Classes
Titre délivré......................................... Service de la Propriété IntellectuelleTitle issued ......................................... Intellectual Property Service
-- LUXEMBOURG- LUXEMBOURG
Demande de Brevet d’invention I. Requête ..La.....société anonyme dite: L’OREAL, 14 rue Royale, 75008.....Paris..* <d - ..Era.ri.ce*.....rap.r.ë.s..e.a.t.é..e.....par....Moii.sieur Charles M u n ç h e n, c ojis..e. il......en.............Invention Patent Application I. Request ..The ..... public limited company called: L'OREAL, 14 rue Royale, 75008 ..... Paris .. * <d - ..Era.ri.ce * ..... rap.r.ë.s..eaté..e ..... by .... Moii.sieur Charles M un ç hen, c ojis..e. it.............
...brevet s...à.....Luxe.fflb..Q.u.rg.*.. en......gu al i té.....de mandataire ?...................... (2) dépose(nt) ce v..lng.trne.uf.....janvier.....19QQ. .gua..tr.e.....v..in.g.t..-d.eux...................... (3) à ...1.5..0.0 heures, au Ministère de l’Économie et des Classes Moyennes, à Luxembourg : 1. la présente requête pour l’obtention d’un brevet d’invention concernant : "Application......d..e.s......bêta.....ami no.....ënones.....comme.....agents.....filtrant.....les (4) .. ........ra d ù.'tùçm.s......U ....y..*.-A............................................................................................................................................................................................................. patent s ... to ..... Luxe.fflb..Qurg. * .. en ...... gu al i té ..... de mandataire? ...... ................ (2) deposit (s) this v..lng.trne.uf ..... January ..... 19QQ. .gua..tr.e ..... v..in.gt.-d.eux ...................... (3) to. ..1.5..0.0 hours, at the Ministry of the Economy and the Middle Classes, in Luxembourg: 1. this request for obtaining a patent for invention concerning: "Application ...... d. .es ..... beta ..... friend no ..... ënones ..... like ..... agents ..... filtering ..... the (4) .. ........ ra d ù.'tùçm.s ...... U .... y .. * .- A ................ .................................................. .................................................. .................................................. ....................................
2. la délégation de pouvoir, datée de . f.d RIS. ».....Er.a.n.CÊ........... le 2.7......j.an.V..î.e.r......1.982..2. the delegation of power, dated. f.d RIS. »..... Er.a.n.CÊ ........... the 2.7 ...... j.an.V..î.e.r ...... 1.982 ..
3. la description en langue ....f.r.Â.n.Ç.a.l.$..e.................................de l’invention en deux exemplaires; 4. ....................planches de dessin, en deux exemplaires; 5. la quittance des taxes versées au Bureau de l'Enregistrement à Luxembourg, ie 2.9.....jmylar......1.98.2...................................................................................................................................................................................................................3. description in language .... frÂ.n.Ç.al $ .. e ............................ ..... of the invention in two copies; 4. .................... drawing boards, in two copies; 5. receipt of taxes paid to the Luxembourg Registration Office, ie 2.9 ..... jmylar ...... 1.98.2 ................. .................................................. .................................................. .................................................. ............................................
déclare(nt) en assumant la responsabilité de cette déclaration, que l’(es) inventeurs) est (sont) : ....................-..........I.................................................................................................................................................................................................................................. (5) revendique(nt) pour la susdite demande de brevet la priorité d’une (des) demande(s) de (6) ..........................n./“.....................................................déposée(s) en (7).................................................................................................................declares (s) assuming responsibility for this declaration, that the inventor (s) is (are): ....................-.... ...... I ........................................... .................................................. .................................................. .................................................. ................................. (5) claims (s) priority for the above patent application one (s) request (s) from (6) .......................... n ./ “........ ............................................. filed in (7) ............................................... .................................................. ................
le ...........................zl.2.............................................................................................................................................................................................................................. (8) * au nom de.....................-/-......................................................................................................................................................................................................... (9) élit(élisent) pour lui (elle) et, si désigné, pour son mandataire, à Luxembourg....................................on ........................... zl.2 ................... .................................................. .................................................. .................................................. .................................................. ... (8) * on behalf of .....................- / -................ .................................................. .................................................. .................................................. ................................... (9) elect (elect) for him / her and, if appointed, for its representative, in Luxembourg ....................................
...X.I.&.,......bo.ul.£v.ä.r.d...,.E.r.i.n.c.e-.HßRr.i.......................................................................................................................................................(ίο) sollicite(nt) la délivrance d’un brevet d’invention pour l’objet décrit et représenté dans les annœp^susmentiom^^^-^avec ajournement de cette délivrance à .d.î.X..“..b..Ult...........................mois. (11) II. Procès-verbal de Dépôt... XI &., ...... bo.ul. £ v.ä.rd ..,. Erince-.HßRr.i ................. .................................................. .................................................. .................................. (ίο) seeks (s) the grant of a patent for invention for the object described and represented in the annœp ^ above ^ ^^^ - ^ with deferment of this delivery to .d.î.X .. “.. b..Ult ............ ...............month. (11) II. Deposit Minutes
La susdite demande de brevet d’invention a été déposée au Ministère de l’Économie et des Classes Moyennes, Service de la Propriété Intellectuelle à Luxembourg, en date du : fj C I K 29 -janvier 1982 ®Pr. le Ministre le l’Économie et des Classes Moyennes, p., _ » t 3. t/5 VéThe aforementioned patent application has been filed with the Ministry of Economy and Middle Classes, Intellectual Property Service in Luxembourg, on: fj C I K 29 -January 1982 ®Pr. the Minister for the Economy and the Middle Classes, p., _ "t 3. t / 5 Vé
1283/81 - GS/MB1283/81 - GS / MB
295295
Société anonyme dite : L'OREALPublic limited company called: L'OREAL
Application des béta amino énones comme agents filtrant les radiations CLV.-A.Application of beta amino enones as agents filtering CLV.-A. radiations
Invention de (j.Invention of (j.
#11 » <# 11 "<
Application âes bêta amino énones comme agents filtrant les radiations U.V.-A.Application to beta amino enones as U.V.-A. radiation screening agents
L'invention concerne des agents absorbants les radiations U.V.-A et leur utilisation dans diverses industries.The invention relates to U.V.-A radiation absorbing agents and their use in various industries.
Il est connu que l'énergie lumineuse absorbée peut provoquer une transformation chimique dans le système qui l'absorbe.It is known that the absorbed light energy can cause a chemical transformation in the system which absorbs it.
Les rayons ultraviolets qui sont des radiations à courte longueur d’onde, sont responsables d'action photochimique sur de nombreux produits organiques tels que matières plastiques, huiles, colorants, etc...Ultraviolet rays, which are short-wavelength radiation, are responsible for photochemical action on many organic products such as plastics, oils, dyes, etc.
Ces actions photochimiques peuvent consister en oxydation, polymérisation, hydrolyse et en général provoquent la dégradation ou la modification de la molécule et peuvent avoir pour conséquence un changement de structure ou "vieillissement" des produits ayant absorbés ces radiations, tels que produits cosmétiques, peintures, matières plastiques; le rancissement des huiles, notamment d'huiles végétales telle que l'huile de noix, l'huile de tournesol; la polymérisation de composés insaturës tels que l'huile de lin et des actions similaires.These photochemical actions can consist in oxidation, polymerization, hydrolysis and in general cause the degradation or the modification of the molecule and can result in a change of structure or "aging" of the products having absorbed these radiations, such as cosmetic products, paints, plastics; the rancidity of oils, in particular vegetable oils such as walnut oil, sunflower oil; polymerization of unsaturated compounds such as linseed oil and the like.
On sait également que les rayons ÜV de la lumière solaire exercent une action sur la peau humaine. C'est ainsi que les rayons Ü.V.-B dont la longueur d'onde est comprise entre 280 . et 320 nm provoquent des erythèmes voire des brûlures. Cependant, les rayons U.V.-A ayant une longueur d'onde de 320 ä 400 nm qui provoquent le brunissement de la peau, provoquent en même temps une altération de celle-ci et peuvent influencer négativement et de façon durable l'aspect et l'état de la peau et plus particulièrement des peaux sensibles ou des parties de la peau exposées continuellement à ces rayons. Ces derniers peuvent provoquer des modifications pathologiques, par exemple des dermatoses.It is also known that the UV rays of sunlight exert an action on human skin. This is how the UV-B rays whose wavelength is between 280. and 320 nm cause erythemas or even burns. However, UV-A rays having a wavelength of 320 to 400 nm which cause browning of the skin, at the same time cause an alteration of the latter and can negatively and durably influence the appearance and the condition of the skin and more particularly of sensitive skin or parts of the skin continuously exposed to these rays. These can cause pathological changes, for example dermatosis.
On a constaté que les rayons U.V.-A pouvaient potentialiser l'action des rayons U.V.-B comme cela a été décrit par plusieurs groupes d'auteurs et plus particulièrement par J.It has been found that U.V.-A rays can potentiate the action of U.V.-B rays as has been described by several groups of authors and more particularly by J.
Willis et al dans "The Journal of Investigative Dermatology" / (volume 59, n° 6, pages 416, 1073) sous le nom de Photo aug-y-Λ mentation. J !/ » i 2Willis et al in "The Journal of Investigative Dermatology" / (volume 59, n ° 6, pages 416, 1073) under the name of Photo aug-y-Λ mentation. J! / »I 2
On sait également que les constituants entrant dans les préparations cosmétiques et en particulier dans des produits de maquillage tels que les vernis à ongles, les bâtons de rouge à lèvres, les fonds de teint anhydres ou les compositions huileuses ne possèdent pas toujours une stabilité suffisante à la lumière et qu'ils se dégradent sous l'action des radiations lumineuses.It is also known that the constituents used in cosmetic preparations and in particular in make-up products such as nail varnishes, lipstick sticks, anhydrous foundations or oily compositions do not always have sufficient stability to light and they degrade under the action of light radiation.
1 D'autres produits et compositions renfermant des colo rants, des huiles, des produits oxydables, subissent une modification sous l'action des rayons U.V.-A.1 Other products and compositions containing dyes, oils, oxidizable products, undergo a modification under the action of UV rays.
Par conséquent, il est souhaitable de disposer d'agents absorbants les radiations U.V.-A et d'être en mesure de protéger les divers produits sensibles à ces radiations ainsi que la peau au moyen de ces agents et de pouvoir incorporer ces agents filtrant les radiations ou rayons ü.V.-A aux produits, préparations et compositions sensibles à ces radiations.Therefore, it is desirable to have agents absorbing UV-A radiations and to be able to protect the various products sensitive to these radiations as well as the skin by means of these agents and to be able to incorporate these agents filtering the radiations. or ü.V.-A rays to products, preparations and compositions sensitive to these radiations.
La demanderesse a découvert que certains dérivés de béta-amino énones absorbent les radiations U.V.-A et conviennent pour la protection de divers produits et compositions sensibles à ces radiations ainsi que pour la protection de la peau.The Applicant has discovered that certain beta-amino enone derivatives absorb UV-A radiation and are suitable for the protection of various products and compositions sensitive to these radiations as well as for the protection of the skin.
L'invention a pour objet l'application de bêta amino “s; énones de formule générale :The invention relates to the application of beta amino “s; enones of general formula:
R HR H
o vUl I V<E2’·» 1<ch2)J (I) où R représente un groupe alkyle linéaire ou ramifié ayant de 1 à 20 atomes de carbone, slcényle linéaire ou ramifié ayant de 1 à 20 atomes de carbone, aryle substitué ou non substitué, aralkyle. substitué ou non substitué, un groupe alicyclique substitué ou non substitué, ou hétérocycle substitué ou non / 1(o vUl IV <E2 '· »1 <ch2) J (I) where R represents a linear or branched alkyl group having from 1 to 20 carbon atoms, linear or branched slenyl having from 1 to 20 carbon atoms, substituted aryl or unsubstituted, aralkyl. substituted or unsubstituted, a substituted or unsubstituted alicyclic group, or substituted or unsubstituted heterocycle / 1 (
* I* I
! 3 j I l'atome d'azote et l'atome de carbone adjacents un hétérocycle substitué ou non substitué contenant de 5 à 20 et de préférence de 6 à 16 atomes de carbone et 1 atome d'azote; R.^ représente un atome d'hydrogène, un groupe alkyle linéaire ou ramifié ayant de 1 à 20 atomes de carbone ou bien forme avec R un cycle comme défini ci-dessus; m désigne 0 (zéro) ou un nombre entier de 1 à 3; R2 représente un groupe alkyle linéaire ou ramifié ayant de 1 à 4 atomes de carbone ou bien forme un cycle adjacent saturé ou un cycle aromatique substitué ou non substitué; lorsque m est supérieur à lfR2 peut représenter des groupes identiques! 3 j I the nitrogen atom and the adjacent carbon atom a substituted or unsubstituted heterocycle containing from 5 to 20 and preferably from 6 to 16 carbon atoms and 1 nitrogen atom; R. ^ represents a hydrogen atom, a linear or branched alkyl group having from 1 to 20 carbon atoms or else forms with R a ring as defined above; m denotes 0 (zero) or an integer from 1 to 3; R2 represents a linear or branched alkyl group having from 1 to 4 carbon atoms or else forms an adjacent saturated ring or a substituted or unsubstituted aromatic ring; when m is greater than lfR2 can represent identical groups
Iou différents; n désigne 0 (zéro) ou un nombre entier de 1 à 15-I or different; n denotes 0 (zero) or an integer from 1 to 15-
Les composés de formule (I) ci-dessus peuvent également être représentés par la formule (II) : Ιΐ R-^ \ ^ H N0 [j— (R2»m <CH2>n <«>The compounds of formula (I) above can also be represented by formula (II): Ιΐ R- ^ \ ^ H N0 [j— (R2 "m <CH2> n <">
Les substituants gardent les mêmes valeurs que celles indiquées pour la formule (I)„ ICe sont d'excellents agents filtrants des radiations ultraviolettes et plus particulièrement des radiations D-V--A-I Ils sont liposolubles, c'est-à-dire solubles dans les huiles,The substituents keep the same values as those indicated for formula (I) „ICe are excellent filtering agents for ultraviolet radiation and more particularly for DV - AI radiation. They are liposoluble, that is to say soluble in oils. ,
Iles cires et autres' corps gras- On peut les associer avantageusement à des agents filtrants les radiations U.V.-B liposolubles- L'invention a également pour objet l'application des J composés de formule (I) ou (II) comme agent filtrant les ! radiations U-V--A ainsi que les compositions contenant ces composés comme agents filtrants- IUn autre objet de l'invention est constitué par un procédé de protection de diverses matières organiques, naturelles ou synthétiques vis-à-vis des rayonnements ultraviolets, y J mettant en oeuvre ces composés de formule (I)- 11/Wax islands and other fatty substances. They can be advantageously combined with liposoluble UV-B radiation filtering agents. The invention also relates to the application of the J compounds of formula (I) or (II) as a filtering agent. ! UV radiation - A as well as the compositions containing these compounds as filtering agents - Another object of the invention consists of a process for the protection of various organic, natural or synthetic materials from ultraviolet radiation, including using these compounds of formula (I) - 11 /
I II I
44
Il est entendu dans la suite de la description que lorsqu'on parle des composés de formule (I), on englobera également la forme tautomere de ces composés de formule (II) ci-dessus indiquée.It is understood in the following description that when talking about the compounds of formula (I), we will also include the tautomeric form of these compounds of formula (II) above indicated.
Les composés de formule (I) filtrent les rayonnements U.V.-A dans la zone comprise entre 320 et 370 nm (nanomëtre). Ces composés de formule (I) utilisés comme agent filtrant les radiations U.V.-A peuvent être préparés par deux méthodes appelées ci-après méthodes A et B, Méthode A.The compounds of formula (I) filter UV radiation in the area between 320 and 370 nm (nanometer). These compounds of formula (I) used as an agent for screening out UV radiation can be prepared by two methods hereinafter called methods A and B, Method A.
(1) Préparation de 1lhydroxymëthylëne-2 cyclohexanone.(1) Preparation of 1-hydroxymethyl-2-cyclohexanone.
Dans un réacteur de 3 litres on place 2 litres d'éther éthyligue anhydre, 98 g de cyclohexanone, 111 g de formiate d'éthyle et 23 g de sodium.2 liters of anhydrous ethyl ether, 98 g of cyclohexanone, 111 g of ethyl formate and 23 g of sodium are placed in a 3-liter reactor.
On agite le mélange, on y ajoute 5 ml d'éthanol pour initier la réaction et on maintient la température à 20°C pendant 6 heures. On abandonne ensuite au repos pendant la nuit. Le lendemain on ajoute 25 ml d'éthanol, on agite le mélange jusqu'à disparition complète du sodium et on ajoute 200 ml d'eau. On décante la phase éthérée, on la lave à l'eau, on la sèche et on concentre sous pression réduite. On distille le résidu sous pression réduite (Eb^Qmm = 83-84°C). On obtient avec un rendement de 76%, 96 g d'hydroxyméthylène-2 cyclohexanone.The mixture is stirred, 5 ml of ethanol are added thereto to initiate the reaction and the temperature is maintained at 20 ° C. for 6 hours. We then give up resting overnight. The following day, 25 ml of ethanol are added, the mixture is stirred until the sodium has completely disappeared and 200 ml of water are added. The ethereal phase is decanted, washed with water, dried and concentrated under reduced pressure. The residue is distilled under reduced pressure (Eb ^ Qmm = 83-84 ° C). 96 g of 2-hydroxymethylene cyclohexanone are obtained with a yield of 76%.
(2) Préparation de la laurylaminométhylëne-2 cyclohexanone(2) Preparation of 2-laurylaminomethylenecyclohexanone
Dans un réacteur de 500 ml, on introduit 38 g d'hydroxy- méthylène-2 cyclohexanone et 100 ml d'éther éthylique. On ajoute une solution contenant 7 6,5 g de laurylamine dans 100 ml d'éther éthylique, l'addition se faisant goutte à goutte, de façon que la température du mélange réactionnel ne dépasse pas 35°C. On agite pendant 15 minutes et on précipite le composé par refroidissement. On sépare le précipité par filtration, on le lave à l'éther et on obtient avec un rendement de 62%, 55 g ce laurylaminométhyiène-2 cyclohexanone. /38 g of 2-hydroxy-methylene cyclohexanone and 100 ml of ethyl ether are introduced into a 500 ml reactor. A solution containing 7 6.5 g of laurylamine in 100 ml of ethyl ether is added, the addition being carried out dropwise, so that the temperature of the reaction mixture does not exceed 35 ° C. The mixture is stirred for 15 minutes and the compound is precipitated by cooling. The precipitate is separated by filtration, washed with ether and 55% of this laurylaminomethyiene-2-cyclohexanone is obtained with a yield of 62%. /
Analyse élémentaire : / /,Elementary analysis: / /,
Λ IΛ I
i 5 î Théorie Trouvé 1 % % I C 77,75 77,87 I H 12,02 12,13 ! N 4,77 4,82 J Absorption U.V. (EtOH) ^max = 328 nm ( £= 17180)i 5 î Theory Found 1%% I C 77.75 77.87 I H 12.02 12.13! N 4.77 4.82 J Absorption U.V. (EtOH) ^ max = 328 nm (£ = 17180)
I Méthode BI Method B
1 Préparation de 1' (oxo-2-cyclohexylidène)-2-aza-l- I . cyclotridécane ..1 Preparation of 1 '(oxo-2-cyclohexylidene) -2-aza-1-I. cyclotridecane ..
Dans un réacteur de 2 litres, on place 236,7 g d'oxime de I · la cyclododécanone, 480 ml de dichloroéthane sec et 150 g de I pyridine» On refroidit la solution à -10°C et on y ajoute, I s dans l'espace de 15 minutes, 212 g de benzène sulfochlorure et I on maintient la réaction pendant 2 heures à 0°C- I On ajoute ensuite, à cette température, 600 g de morpho- 1 lino-1 cyclohexène, en l'espace de 30 minutes, on rechauffe le S mélange réactionnel à 30°C et on agite à cette température i pendant environ 20 heures» I On hydrolyse ensuite le mélange réactionnel pendant 4 * heures, ä 20°C, au moyen de 150 ml d'acide acétigue à 50%, i puis on y ajoute 1,2 litre de NaOH 6N. On décante le mélange, I on traite la phase aqueuse avec du dichloroéthane et on lave i les extraits organigues avec de l'eau, on sèche sur du sulfate • de sodium et on concentre jusqu'à siccitë» i On distille le résidu sous vide (EbQ 5mm = 180-195°C)« i On obtient, avec un rendement de 70%, 233 g de 1' (oxo-2-cy- « clohexylidène)-2-aza-l-cyclotridécane.236.7 g of oxime of cyclododecanone, 480 ml of dry dichloroethane and 150 g of pyridine are placed in a 2-liter reactor. The solution is cooled to -10 ° C. and added to it. in the space of 15 minutes, 212 g of benzene sulfochloride and I the reaction is maintained for 2 hours at 0 ° C.- I 600 g of 1-lino-1-cyclohexene is then added at this temperature. For 30 minutes, the reaction mixture is warmed to 30 ° C. and stirred at this temperature i for approximately 20 hours. I The reaction mixture is then hydrolyzed for 4 hours at 20 ° C. using 150 ml of 'Acetic acid 50%, i then added 1.2 liters of NaOH 6N. The mixture is decanted, the aqueous phase is treated with dichloroethane and the organic extracts are washed with water, dried over sodium sulfate and concentrated to dryness. The residue is distilled in vacuo (EbQ 5mm = 180-195 ° C) "i Obtain, with a yield of 70%, 233 g of 1 '(oxo-2-cy-" clohexylidene) -2-aza-1-cyclotridecane.
I Analayse élémentaire : , 1 . Théorie Trouvé i % % I C 77,90 C 77,99 i H 11,19 H 11,24 1 N 5,05 N 5,16 I Par le procédé (A) ci-dessus indiqué on prépare également I le N (trimëthyl-2,4,6-anilino)méthylène-2-cyclohexanone et la : I cyclohexylamino-méthylène-2-cyclohexanone» î Par le procédé (B) ci-dessus on prépare l'/bxo-2-cyclojae- I xylidènej7-2 aza-l-cycloheptane» / / Ψ 6I Elementary analysis:, 1. Theory Found i%% CI 77.90 C 77.99 i H 11.19 H 11.24 1 N 5.05 N 5.16 I By the process (A) above indicated I is also prepared N (trimethyl -2,4,6-anilino) methylene-2-cyclohexanone and the: I cyclohexylamino-methylene-2-cyclohexanone "î By process (B) above, the / bxo-2-cyclojae- I xylidene is prepared. 2 aza-l-cycloheptane "/ / Ψ 6
Les caractéristiques des béta amino énones préparées figurent sur le tableau I ci-après.The characteristics of the beta amino enones prepared are shown in Table I below.
Ces caractéristiques sont : (1) formule développée, (2) formule brute et poids moléculaire, (3) analyse élémentaire : pourcentage C, H, N théorigue et trouvé, (4) procédé de préparation A ou B, (5) longueur d'onde correspondant au maximum d'absorption ( Λ max), exprimée en nanomètres, (6) coefficient d’extinction molaire (£) » (7) solvant utilisé, j i 7 SS tu -Γ1 pj PP OU oThese characteristics are: (1) structural formula, (2) gross formula and molecular weight, (3) elementary analysis: percentage C, H, N theorigue and found, (4) preparation process A or B, (5) length d 'wave corresponding to the maximum absorption (Λ max), expressed in nanometers, (6) molar extinction coefficient (£)' (7) solvent used, ji 7 SS tu -Γ1 pj PP OR o
H H H SH H H S
W W W U WW W W U W
II | ° ο ο Ο o MJ 00 vo -et so vbII | ° ο ο Ο o MJ 00 vo -et so vb
*-· Ό i—I SD* - · Ό i — I SD
O cm m enO cm m in
^ <N CS t—I rH^ <N CS t — I rH
XX
CDCD
Ë Q ' Ë oo os «t O r- N<^C cs es co <t co s-—' co co co co <o c 0) o α ·ηË Q 'Ë oo os «t O r- N <^ C cs es co <t co s-—' co co co co <o c 0) o α · η
’ 4J’4D
CP « α vj g < < < m pq O vl) tu uCP "α vj g <<<m pq O vl) tu u
FW FWFW FW
<u l·) VU n- co M cn cn r-H 00 Os Os -tO l— cn in<u l ·) VU n- co M cn cn r-H 00 Os Os -tO l— cn in
•H > 00 r—I CO Γ^Γ>·Γ>· O ls VÛ OscnJi-I <f 00 H• H> 00 r — I CO Γ ^ Γ> · Γ> · O ls VÛ OscnJi-I <f 00 H
COO « ·> * --- - - - - - - -t-i O t'- es) -t mosvo οι oo in r— »—i <f σι n C Fi r-' i—t r'' r-» i r·-COO “·> * --- - - - - - - -ti O t'- es) -t mosvo οι oo in r—” —i <f σι n C Fi r- 'i — t r' 'r- »Ir · -
0) AJ0) AJ
BB
vu H <-<_____ VD ---— —- !=> m n η- OO P os η- O m cn m <! <u o) O r-- so ’ osr^-r^. ® η o γ-h m PQ cn-r) - - - - " - - - - „ in Cn cs >—< to Pi cs -t in P so cn co m in h in - - -seen H <- <_____ VD ---— —-! => m n η- OO P os η- O m cn m <! <u o) O r-- so ’osr ^ -r ^. ® η o γ-h m PQ cn-r) - - - - "- - - -„ in Cn cs> - <to Pi cs -t in P so cn co m in h in - - -
FprWO r^i-i Γ'-'-1 n. c^t-w sf osn < co vu r-- H ti Xi &-?&£$£ Β-Ϊ B-S Β-Ϊ B-S BS B-S „ „ < *j owa ο κ jg ü sg bwfe ^ U K g (U I 4J o D ü Fl VU Λ τ-Ι 2 0 is ja ω 6 ΐδ ο.ο Ο Ο τ ί ΙΠ τ—! »7 g » g iJ0 <Ν ΓΟ ^ rW . en F 2 Η W " W " es co co -t iH co ^•rjv-i σ\ en m r*· ju « a ^ · w i O O flj r-1 θ’* r-iO VO CO CO Γ-'* cslroFprWO r ^ i-i Γ '-'- 1 n. c ^ tw sf osn <co vu r-- H ti Xi & -? & £ $ £ Β-Ϊ BS Β-Ϊ BS BS BS „„ <* j owa ο κ jg ü sg bwfe ^ UK g (UI 4J o D ü Fl VU Λ τ-Ι 2 0 is ja ω 6 ΐδ ο.ο Ο Ο τ ί ΙΠ τ—! »7 g» g iJ0 <Ν ΓΟ ^ rW. In F 2 Η W "W" es co co - t iH co ^ • rjv-i σ \ en mr * · ju «a ^ · wi OO flj r-1 θ '* r-iO VO CO CO Γ -' * cslro
FwFW-i O cS U es h 3 H n SSFwFW-i O cS U es h 3 H n SS
O CS O CS u «-SO CS O CS u «-S
COCO
KK
o τ-S co î f Q àr ,“9 =P> σ o S J g J3-0 7 ® é s \ — -Λ »—°-v U3aMaw 8o τ-S co î f Q àr, “9 = P> σ o S J g J3-0 7 ® é s \ - -Λ” - ° -v U3aMaw 8
La présente invention vise également les compositions contenant au moins une béta amino énone de formule (I) ou (II) associée à un agent absorbant les radiations U.V.-B de longueur d’onde comprise entre 290 et 320 nm ainsi gu’éventuellement d’autres agents absorbant les radiations U.V.-A. On peut ainsi obtenir des compositions filtrant l'ensemble des rayonnements U.V.-B et U.V„-A„ A titre d'agent absorbant les radiations U.V-B on peut citer des dérivés de l'acide salicyligue tels gue le salicy-late de 2-éthyl-hexyle, le salicylate d'homomenthyle, des dérivés de l'acide cinnamigue tels gue 1'éthylhexyl-p-méthoxy-cinnamate, le 2-éthoxyéthyl~p-méthoxycinnamate, des dérivés de l'acide paraaminobenzoîgue tel gue le paradiméthylamino et le paraaminobenzoate d'amyle, le 2-éthyl hexylparadiméthylamino-benzoate, des dérivés de la benzophénone tels gue la 2-hydroxy 4-méthoxybenzophénone, la 2,2'-dihydroxy 4-méthoxybenzophé-none, des dérivés du camphre tel gue le benzylidène camphre, le (mëthyl-4 benzylidène)-3 camphre associé éventuellement avec 1'isopropyl-4 dibenzoylméthane, et des dérivés liposo-lubles décrits dans la demande de brevet français 2.383-904.The present invention also relates to the compositions containing at least one beta amino enone of formula (I) or (II) associated with an agent absorbing UV-B radiation of wavelength between 290 and 320 nm as well as possibly other UV-A absorbing agents. It is thus possible to obtain compositions filtering all of the UV-B and UV "-A" radiation. As an agent absorbing UV-B radiation, mention may be made of salicylic acid derivatives such as the salicy-late of 2 -ethyl-hexyl, homomenthyl salicylate, cinnamigue acid derivatives such as ethylhexyl-p-methoxy-cinnamate, 2-ethoxyethyl ~ p-methoxycinnamate, paraaminobenzoic acid derivatives such as paradimethylamino and amyl paraaminobenzoate, 2-ethyl hexylparadimethylamino-benzoate, benzophenone derivatives such as 2-hydroxy 4-methoxybenzophenone, 2,2'-dihydroxy 4-methoxybenzophen-none, camphor derivatives such as benzylidene camphor, (4-methylbenzylidene) -3 camphor optionally combined with 4-isopropyl-dibenzoylmethane, and liposoluble derivatives described in French patent application 2,383-904.
Comme corps gras pouvant être associé au composé de formule (I) ou (II) selon l'invention, on peut citer les huiles minérales telles gue l'huile de vaseline ou le pétro-„ latum, les huiles animales telles gue les huiles de baleine, de phogue, de menhaden, de foie de flétan, de foie de morue, de thon, de tortue, de suif, de pied de boeuf, de pied de cheval, de pied de mouton, de vison, de loutre, de marmotte et huiles similaires; les huiles végétales telles gue les huiles d'amande, d'arachide, de germe de blé, de lin, de noyaux d'abricots, de noix, de palme, de pistache, de sésame, d'oeillette, de pin, de ricin, de soja, d'avocat, de carthame, de coco, de noisette, d'olive, de pépins de raisins, de tournesol, de colza, de cade, de germe de maïs, de noyaux de pêche, de café, de jojoba et huiles similaires; les glycérides d'acides gras tels gue les triglycérides d'acides gras ayant de 6 à 12 atomes de carbone, et les triglycérides concrets a 25°C; les / esters d'acides gras tels gue les esters isopropyligues des, /As fatty substances which can be combined with the compound of formula (I) or (II) according to the invention, mention may be made of mineral oils such as petrolatum oil or petro-latum, animal oils such as whale, drug, menhaden, halibut, cod liver, tuna, turtle, tallow, ox's foot, horse's foot, sheep's foot, mink, otter, groundhog and similar oils; vegetable oils such as almond, peanut, wheat germ, flax, apricot kernel, walnut, palm, pistachio, sesame, flaxseed, pine, castor oil , soy, avocado, safflower, coconut, hazelnut, olive, grape seed, sunflower, rapeseed, cade, corn germ, peach kernels, coffee, jojoba and similar oils; fatty acid glycerides such as fatty acid triglycerides having 6 to 12 carbon atoms, and concrete triglycerides at 25 ° C; fatty acid esters such as isopropyl esters of, /
UU
. f' · i. f '· i
UU
; i, i 9 I acides myristique, palmitique et stéarique, les esters gras concrets à 25°C; l'ozokérite, la vaseline, la paraffine, la lanoline, la lanoline hydrogénée, la lanoline acétylée, les cires telles que la cire de lanoline, la cire d'abeille, la cire de Candellila, la cire microcristalline, la cire de Carnauba, le spermaceti, le beurre de cacao, le beurre de karité, les cires de silicone telles que les méthyloctadé-cane-oxypolysiloxane et le poly(diméthylsiloxy) stéaroxysi-loxane, les huiles hydrogénées concrètes à 25°C; les sucro-glycérides; les oléates, myristates, lanolates et stéarates de Ca, Mg, Zr et Allés compositions selon l'invention peuvent se présenter sous différentes formes notamment de solution, de lotion j huileuse, de gel gras, de pommade et peuvent être condition nées sous forme d'aérosol.; i, i 9 I myristic, palmitic and stearic acids, concrete fatty esters at 25 ° C; ozokerite, petrolatum, paraffin, lanolin, hydrogenated lanolin, acetylated lanolin, waxes such as lanolin wax, beeswax, candellila wax, microcrystalline wax, carnauba wax, spermaceti, cocoa butter, shea butter, silicone waxes such as methyloctade-cane-oxypolysiloxane and poly (dimethylsiloxy) stearoxysiloxane, hydrogenated oils concrete at 25 ° C; the sugar glycerides; the oleates, myristates, lanolates and stearates of Ca, Mg, Zr and Allés compositions according to the invention can be in various forms, in particular of solution, oily lotion, fatty gel, ointment and can be provided in the form of 'aerosol.
Lorsque la composition selon l'invention est une composition cosmétique elle peut être utilisée comme composition destinée à protéger l'épiderme humain contre les rayons ultraviolets.When the composition according to the invention is a cosmetic composition it can be used as a composition intended to protect the human epidermis against ultraviolet rays.
La composition cosmétique selon l'invention peut également se présenter sous d'autres formes notamment comme une composition huileuse lavante pour les cheveux ou le corps, un ·} produit de maquillage tel qu'un vernis à ongles, bâton de rouge à lèvres, fond de teint.The cosmetic composition according to the invention can also be presented in other forms, in particular as an oily washing composition for the hair or the body, a make-up product such as a nail varnish, lipstick stick, background. complexion.
Les compositions cosmétiques selon l'invention peuvent contenir des adjuvants habituellement utilisés en cosmétique, notamment des épaississants, des adoucissants, des surgrais-sants, des émollients, des conservateurs, des anti-oxydants, ^ des parfums, des colorants, des pigments, des polymères cos- ' métiques, des tensio-actifs oléosolubles.The cosmetic compositions according to the invention may contain adjuvants usually used in cosmetics, in particular thickeners, softeners, superfats, emollients, preservatives, antioxidants, perfumes, dyes, pigments, cosmetical polymers, oil-soluble surfactants.
Les composés de formule (I) ou (II) sont généralement présents dans les compositions selon l'invention dans des f proportions en poids de 0,05 à 15% et de préférence de 0,5 à 10%.The compounds of formula (I) or (II) are generally present in the compositions according to the invention in proportions by weight of 0.05 to 15% and preferably from 0.5 to 10%.
I L'invention a également pour objet un procédé de protec tion de l'épiderme humain contre les rayons ü.V.-A caractérisé par le fait que l'on applique sur la peau un composé de forf j 10 mule (I) ou (II) éventuellement associé à d'autres agents absorbant les rayons U»V»-A et/ou U*V»-B» L'invention a également pour objet un procédé de protection de matières organigues naturelles ou synthétiques consistant à leur incorporer au moins un composé de formule (I) ou (II) ou de les associer ä un tel composé* Parmi les matières pouvant être protégées par les composés (I) ou (II) on peut citer les matières plastiques synthétiques, les huiles alimentaires telles que par exemple l'huile de noix, l'huile de tournesol, ainsi que d'autres huiles oxydables» L'invention est illustrée par les exemples d'application non limitatifs ci-après» //I The subject of the invention is also a method of protecting the human epidermis against UV rays, characterized in that a compound of formula 10 is applied to the skin (I) or (II) optionally combined with other agents absorbing U ”V” -A and / or U * V ”-B” rays. The invention also relates to a process for the protection of natural or synthetic organic materials consisting in incorporating them at least one compound of formula (I) or (II) or to associate them with such a compound * Among the materials which can be protected by compounds (I) or (II), mention may be made of synthetic plastics, edible oils such as as for example walnut oil, sunflower oil, as well as other oxidizable oils "The invention is illustrated by the nonlimiting application examples below" //
a Ihave
11 EXEMPLES D'APPLICATION Exemple 1 ; huile solaire /oxo-2 cyclohexylidène.7-2-aza-l cyclotridécane 4 g Benzylidène-3 camphre 3 g11 APPLICATION EXAMPLES Example 1; sun oil / oxo-2 cyclohexylidene. 7-2-aza-l cyclotridecane 4 g Benzylidene-3 camphor 3 g
Antioxydants q„s„ (quantité suffisante)Antioxidants q „s„ (sufficient quantity)
Parfum 0,5 gPerfume 0.5 g
Huile de colza q.s.p* 100 g * Exemple 2 : bâton solaire /oxo-2-cyclohexylidène7-2-aza-l cycloheptane 2,5 g p-méthoxycinnamate d'éthyl-2 hexyle 2,5 gRapeseed oil q.s.p * 100 g * Example 2: solar stick / oxo-2-cyclohexylidene7-2-aza-l cycloheptane 2.5 g p-2-ethylhexyl methoxycinnamate 2.5 g
Beurre de cacao 12 gCocoa butter 12 g
Cire ozokérite 8 g ! Paraffine 3 gOzokerite wax 8 g! Paraffin 3 g
Huile de café 10 gCoffee oil 10 g
Lanoline 10 gLanolin 10 g
Antioxydants q„s„Antioxidants q „s„
Parfum 0,5 gPerfume 0.5 g
Huile de vaseline q.s.p. 100 gVaseline oil q.s.p. 100g
Exemple 3 ; Pommade solaireExample 3; Sun ointment
Laurylaminométhylène-2-cyclohexanone 5 gLaurylaminomethylene-2-cyclohexanone 5 g
Acide octyl diméthyl p-aminobenzoïque 4 gOctyl dimethyl p-aminobenzoic acid 4 g
Beurre de cacao 10 gCocoa butter 10 g
Huile de coco 15-g . Beurre de karité 3 gCoconut oil 15-g. Shea butter 3 g
Vaseline blanche 45 g , Cire ozokérite 3 gWhite petrolatum 45 g, Ozokerite wax 3 g
Antioxydants q.s.Antioxidants q.s.
I Parfum 1 gI Perfume 1 g
Huile de colza q-s*p. 100 gRapeseed oil q-s * p. 100g
Exemple 4 : gel solaire N/rtrimêthyl-2,4,6 anilino/méthylène-2- cyclohexanone 3,5 gEXAMPLE 4 Sun gel N / 2,4,4,6 anilino / methylene-2-cyclohexanone 3,5 g
Vaseline blanche 20 gWhite Vaseline 20 g
Silice 2 gSilica 2 g
Stéarate de magnésium 10 gMagnesium stearate 10 g
Lanoline liquide 3 gLiquid Lanolin 3 g
Huile de café 8 g 12Coffee oil 8 g 12
Benzyliâène-3 camphre 2,5 gBenzylien-3 camphor 2.5 g
Parfum 1 gPerfume 1 g
Huile de vaseline q-s.p. 100 gVaseline oil q-s.p. 100g
Exemple 5Example 5
Cet exemple est identique à l’exemple 4 sauf que les 3,5 g de N(triméthyl-2,4,6 anilino)méthylène-2 cyclohexanone sont remplacés par le même poids de 1'(oxo-2-cyclohexylidène)-> 2-aza 1-cyclotridécane*This example is identical to Example 4 except that the 3.5 g of N (2,4,6,6-anilino) methylene-2 cyclohexanone are replaced by the same weight of 1 '(oxo-2-cyclohexylidene) -> 2-aza 1-cyclotridecane *
Exemple 6 : gel solaireEXAMPLE 6 Sun Gel
Cyclohexylamino méthylène-2-cyclohexanone 2,5 gCyclohexylamino methylene-2-cyclohexanone 2.5 g
Vaseline blanche 30 gWhite Vaseline 30 g
Silice 3 gSilica 3 g
Stéarate de magnésium 12 gMagnesium stearate 12 g
Lanoline liquide 1 gLiquid lanolin 1 g
Huile de colza 12 g p-méthoxy cinnamate d'éthyl-2 hexyle 4,5 gCanola oil 12 g 2-ethylhexyl p-methoxy cinnamate 4.5 g
Conservateurs q„s* /Preservatives q „s * /
Huile de vaseline q.s-p- 100 g-/· /Vaseline oil q.s-p- 100 g- / · /
TT
Claims (14)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU83912A LU83912A1 (en) | 1982-01-29 | 1982-01-29 | APPLICATION OF BETA AMINO ENONES AS U.V.-A. RADIATION FILTERING AGENTS |
| FR8301391A FR2520615A1 (en) | 1982-01-29 | 1983-01-28 | Sunscreen cosmetic compsns. - contg. 2-aminomethylene-cycloalkanone cpds. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU83912 | 1982-01-29 | ||
| LU83912A LU83912A1 (en) | 1982-01-29 | 1982-01-29 | APPLICATION OF BETA AMINO ENONES AS U.V.-A. RADIATION FILTERING AGENTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU83912A1 true LU83912A1 (en) | 1983-09-02 |
Family
ID=19729806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU83912A LU83912A1 (en) | 1982-01-29 | 1982-01-29 | APPLICATION OF BETA AMINO ENONES AS U.V.-A. RADIATION FILTERING AGENTS |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR2520615A1 (en) |
| LU (1) | LU83912A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4514383A (en) * | 1982-05-05 | 1985-04-30 | Johnson & Johnson Baby Products Company | Sunscreen compositions containing vinylogous amides |
| FI875686L (en) * | 1986-12-30 | 1988-07-01 | Ritz Group Ltd Charles | UV-ABSORBERANDE FOERENINGAR OCH KOMPOSITIONER INNEHAOLLANDE DESSA. |
| DE19904329A1 (en) * | 1999-01-28 | 2000-08-03 | Cognis Deutschland Gmbh | Cosmetic and / or pharmaceutical preparations |
| FR2801505B1 (en) * | 1999-11-26 | 2002-02-01 | Arnaud Ruel | DERMO-COSMETOLOGICAL COMPOSITION OF CARE COMPRISING AMONG OTHERS RICE STARCH, COCONUT OIL AND SHEA BUTTER |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1147573B (en) * | 1960-03-04 | 1963-04-25 | Bayer Ag | Process for the preparation of aminomethylene compounds |
| FR1372838A (en) * | 1962-10-13 | 1964-09-18 | Basf Ag | Bicyclic compounds and process for their preparation |
| DE2728241A1 (en) * | 1977-06-23 | 1979-01-11 | Henkel Kgaa | COSMETIC LIGHT PROTECTION AGENTS FOR THE UV-A AREA |
-
1982
- 1982-01-29 LU LU83912A patent/LU83912A1/en unknown
-
1983
- 1983-01-28 FR FR8301391A patent/FR2520615A1/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2520615B1 (en) | 1985-05-10 |
| FR2520615A1 (en) | 1983-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0507692B1 (en) | S-Triazine derivatives substituted with benzylenecampher, process for their preparation, filtering cosmetic compositions containing them and their use as UV protectors for skin and hair | |
| EP0944624B1 (en) | Insoluble s-triazine derivatives and their use as uv filters | |
| CA1258638A (en) | Cosmetic composition comprising aloesine as protecting agent against de sun rays and use for the protection of the skin and hair | |
| BE1000652A4 (en) | COSMETIC COMPOSITION CONTAINING HYDROXYLATED CHALCON DERIVATIVES AND ITS USE FOR PROTECTING THE SKIN AND HAIR AGAINST LIGHT RADIATION, NEW HYDROXYLATED CHALCONE DERIVATIVES AND THEIR PREPARATION METHOD. | |
| CA1202327A (en) | Cosmetic compositions containing hydroxylated dibenzoylmethane derivatives and their use for protecting human skin against ultraviolet radiation; new hydroxylated dibenzoylmethane derivatives used and process for preparing the same | |
| CA2197346C (en) | New insoluble derivatives of s-triazine, their preparation process, compounds containing them and their uses | |
| CA1204779A (en) | 3-benzylidene camphors; process for preparing the same and their use as protective agents against uv radiation | |
| EP0368717B1 (en) | 5-benzylidene 3-oxa cyclopentanone derivatives, process for their manufacture and their use in cosmetic compositions to protect the skin and the hair against sun radiation | |
| CA1298789C (en) | Photostable composition compound containing ethylrutin derivative as protective agent against sun light and use thereof for skin and hair protection | |
| CH662728A5 (en) | FILTERING SOLAR COMPOSITION CONTAINING POLYISOBUTYLENE. | |
| CA2064930A1 (en) | S-triazinic derivatives having benzylidene camphre substituants, their preparation process, filtrating cosmetic compositions containing them and their use to protect the skin and hair against ultra-violet radition | |
| EP0293579B2 (en) | Cosmetic composition for protection against UV radiations containing a cupric complex of 3,5-diisopropyl-salicylic acid, and the cosmetic use of such a compound | |
| FR2540380A1 (en) | COSMETIC COMPOSITION FOR PROTECTION AGAINST ULTRAVIOLET RADIATION AND USE THEREOF | |
| FR2597476A1 (en) | BENZYLIDENIC COMPOUNDS, COMPOSITIONS CONTAINING SAME, AND ULTRAVIOLET RADIATION - ABSORBING AGENTS THEREOF. | |
| FR2717808A1 (en) | Cosmetic sunscreen compsns. contg. UV-A filters | |
| CA1303999C (en) | Filtrating cosmetic composition in the form of an oil-in-water emulsion comprising a uv-a and a uv-b filter and its use for protecting the skin against ultra-violet rays | |
| LU83912A1 (en) | APPLICATION OF BETA AMINO ENONES AS U.V.-A. RADIATION FILTERING AGENTS | |
| FR2624508A1 (en) | NOVEL TERTIBUTYL DERIVATIVES OF BENZYLIDENE CAMPHOR, PROCESS FOR THE PREPARATION THEREOF, USE THEREOF AS ANTI-OXIDIZING AGENTS AND COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | |
| WO2002056858A1 (en) | Solar protection compositions | |
| CH677111A5 (en) | ||
| FR2526658A2 (en) | Cosmetic compsn. contg. 2-hydroxy di:benzoyl:methane deriv. - having good UV ray filtration properties and solubility in cosmetic media | |
| CH679668A5 (en) | ||
| FR2488252A1 (en) | QUATERNARY DIBENZOYLMETHANE DERIVATIVES, THEIR USE AS A SOLAR FILTERING AGENT AND COSMETIC COMPOSITION CONTAINING THEM |